SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-074846
Filing Date
2024-06-18
Accepted
2024-06-18 16:06:18
Documents
11
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K prld-20240614.htm   iXBRL 8-K 54702
  Complete submission text file 0000950170-24-074846.txt   193583

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20240614.xsd EX-101.SCH 45351
14 EXTRACTED XBRL INSTANCE DOCUMENT prld-20240614_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 241051726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)